The data shown below were collected from the profiles of 72 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial
|
|---|---|
| Published in |
The Lancet, July 2021
|
| DOI | 10.1016/s0140-6736(21)00766-2 |
| Pubmed ID | |
| Authors |
Jonathan G Moss, Olivia Wu, Andrew R Bodenham, Roshan Agarwal, Tobias F Menne, Brian L Jones, Robert Heggie, Steve Hill, Judith Dixon-Hughes, Eileen Soulis, Evi Germeni, Susan Dillon, Elaine McCartney, CAVA trial group |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 18 | 25% |
| France | 3 | 4% |
| United States | 2 | 3% |
| Singapore | 2 | 3% |
| Brazil | 2 | 3% |
| Saint Martin (French part) | 1 | 1% |
| Sweden | 1 | 1% |
| Mexico | 1 | 1% |
| Ireland | 1 | 1% |
| Other | 1 | 1% |
| Unknown | 40 | 56% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 41 | 57% |
| Practitioners (doctors, other healthcare professionals) | 23 | 32% |
| Scientists | 5 | 7% |
| Science communicators (journalists, bloggers, editors) | 3 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 129 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 129 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 11 | 9% |
| Other | 8 | 6% |
| Student > Ph. D. Student | 8 | 6% |
| Student > Master | 7 | 5% |
| Student > Postgraduate | 6 | 5% |
| Other | 20 | 16% |
| Unknown | 69 | 53% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 45 | 35% |
| Nursing and Health Professions | 10 | 8% |
| Biochemistry, Genetics and Molecular Biology | 2 | 2% |
| Business, Management and Accounting | 1 | <1% |
| Computer Science | 1 | <1% |
| Other | 3 | 2% |
| Unknown | 67 | 52% |
Attention Score in Context
This research output has an Altmetric Attention Score of 74. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 September 2023.
All research outputs
#593,763
of 25,971,360 outputs
Outputs from The Lancet
#5,262
of 43,145 outputs
Outputs of similar age
#15,080
of 449,127 outputs
Outputs of similar age from The Lancet
#116
of 387 outputs
Altmetric has tracked 25,971,360 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 43,145 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 68.0. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 449,127 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 387 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.